Notwithstanding this debate, anti-tumor effects observed when depleting PTK7 expression, as exemplified in our study as in others, indicate that it may represent a valuable target for different cancer therapeutics including CRC. This evidence concerns the gene PTK7 and colorectal carcinoma.